miR-29, a potential therapeutic target for liver fibrosis

Gene. 2014 Jul 10;544(2):259-60. doi: 10.1016/j.gene.2014.04.076. Epub 2014 May 2.

Authors

Er-Bao Bian¹, Jia Li¹, Bing Zhao²

Affiliations

¹ Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
² Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China. Electronic address: aydzhb@126.com.

PMID: 24792894
DOI: 10.1016/j.gene.2014.04.076

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Hepatic Stellate Cells / metabolism*
Insulin-Like Growth Factor I / metabolism*
Lymphokines / metabolism*
MicroRNAs / metabolism*
Platelet-Derived Growth Factor / metabolism*

Substances

Lymphokines
MicroRNAs
Platelet-Derived Growth Factor
Insulin-Like Growth Factor I